Top Clinical Trials companies in France by Free Cash Flow Per Share
France
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -0.38
|
Dec. 31, 2023 | USD 2.14 | -0.29% |
|
France |
|
| 2 |
USD -0.49
|
Dec. 31, 2023 | USD 1.58 | 0.37% |
|
France |
|
| 3 |
USD -0.50
|
March 31, 2024 | USD 16.15 | -3.27% |
|
France |
|
| 4 |
USD -0.51
|
Dec. 31, 2023 | USD 6.11 | -1.79% |
|
France |
|
| 5 |
USD -0.74
|
Dec. 31, 2023 | USD 1.42 | -2.42% |
|
France |
|
| 6 |
USD -0.84
|
Dec. 31, 2023 | USD 4.26 | 0.95% |
|
France |
|
| 7 |
USD -1.13
|
Dec. 31, 2023 | USD 6.91 | 1.86% |
|
France |
|
| 8 |
USD -1.28
|
Dec. 31, 2023 | USD 3.82 | 3.95% |
|
France |
|
| 9 |
USD -1.92
|
Dec. 31, 2023 | USD 8.25 | -0.54% |
|
France |
|
| 10 |
USD -2.00
|
Dec. 31, 2023 | USD 2.41 | 7.10% |
|
France |
|
| 11 |
USD -2.50
|
Dec. 31, 2023 | USD 6.10 | -0.29% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest Free Cash Flow Per Share ?
The Clinical Trials company in France with the highest Free Cash Flow Per Share is Crossject SA (Paris Stock Exchange: ALCJ.PA) at USD -0.38.
-
Which Clinical Trials company in France has the lowest Free Cash Flow Per Share ?
The Clinical Trials company in France with the lowest Free Cash Flow Per Share is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at USD -2.50.
-
What are the top 10 Clinical Trials companies in France by Free Cash Flow Per Share ?
The top 10 Clinical Trials companies in France by Free Cash Flow Per Share are Crossject SA, Cellectis S.A., MedinCell S.A., Adocia SA, Valbiotis SA, DBV Technologies S.A., OSE Immunotherapeutics SA, Genfit S.A., MaaT Pharma SA and Inventiva S.A..
-
What are the bottom 10 Clinical Trials companies in France by Free Cash Flow Per Share ?
The bottom 10 Clinical Trials companies in France by Free Cash Flow Per Share are ABIVAX SA, Inventiva S.A., MaaT Pharma SA, Genfit S.A., OSE Immunotherapeutics SA, DBV Technologies S.A., Valbiotis SA, Adocia SA, MedinCell S.A. and Cellectis S.A..
